Debiopharm

Debiopharm is an independent biopharmaceutical company based in Switzerland, dedicated to developing the standard of care for curing cancer and infectious diseases. Established in 1979, the company focuses on drug development, manufacturing, and investment in digital health. With a commitment to innovative solutions, Debiopharm in-licenses promising compounds to develop and out-license as medications. It consists of three divisions: Debiopharm International, Debiopharm Research & Manufacturing, and Debiopharm Innovation Fund, which also invests in digital health and smart data start-ups.